10 瓶組庫存 6省 22%CJC-1295 + Ipamorelin 5 mg + 5 mg
經典 GHRH + 飢餓素模擬物組合
CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.
僅供研究使用。 本化合物嚴格用於體外研究及實驗室用途，不得供人體食用或治療用途。購買即確認您為合格研究者，並同意我們的 完整免責聲明。
只剩 6 組
將 CJC-1295（GHRH 類似物）與選擇性飢餓素模擬物 Ipamorelin 配於同一研究用瓶。胜肽研究中最常被研究的雙機制 GH 促分泌組合。
CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.
Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.
作用機制
CJC-1295 支援基礎 GHRH 受體訊號，Ipamorelin 驅動選擇性飢餓素受體脈衝。研究顯示在研究對象中產生協同、接近生理節律的 GH 釋放模式。
經 HPLC 驗證，純度規格 ≥99%。由獲認可的第三方實驗室獨立檢測。
CJC-1295: DAC vs no-DAC
CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.
CJC-1295 + Ipamorelin — 常见問題
What is the CJC-1295 + Ipamorelin stack?
It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.
How does CJC-1295 differ from Ipamorelin?
CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.
Is CJC-1295 + Ipamorelin legal in Australia?
Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.
What does selective mean for Ipamorelin?
Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.
What is the typical CJC-1295 + Ipamorelin research dosage?
Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Are CJC-1295 and Ipamorelin used together?
Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.
與 CJC-1295 + Ipamorelin 相關的指南
研究者還會瀏覽
精選10 瓶組省 22%Melanotan II
凍乾粉末10 mg
α-MSH 類似物研究用胜肽